Alafair Biosciences, a leading innovator in medical device technology, announced that it has been named to Inc.'s 2025 Best Workplaces list. Driven by a culture that empowers its team, fosters innovation, and maintains a steadfast commitment to improving patient outcomes, Alafair is proud to be recognized by this prestigious honor.
The award process involved a detailed employee survey conducted by Quantum Workplace, covering critical elements such as management effectiveness, perks, professional development, and overall company philosophy. Each company's benefits were also audited to determine overall score and ranking. Alafair Biosciences is honored to be included among the 514 companies recognized this year.
"Since our founding, we've purposefully fostered a culture where our people feel valued and embrace the mission of helping surgeons deliver the best possible outcomes for their patients. These principles have been the cornerstone in achieving industry leading revenue growth and in expanding surgeon adoption of VersaWrap® Hydrogel Sheet across the US," said John Joyoprayitno, President & CEO of Alafair Biosciences.
VersaWrap Hydrogel Sheet is a hyaluronic acid and alginate hydrogel engineered to enhance tissue gliding and reduce soft-tissue tethering. In published clinical studies, VersaWrap demonstrates promising results in tendon and nerve repair procedures, supporting its role in minimizing scarring and improving post-operative function. With over 27,000 implants in the United States, VersaWrap is trusted by surgeons nationwide as a reliable adjunct in soft-tissue protection.
This recognition by Inc. reinforces Alafair's belief that advancing patient care starts with investing in its people. The Inc. Best Workplaces designation not only validates Alafair's investment in its people but also positions the company to attract top talent as it scales operations and advances its mission to transform surgical outcomes. With VersaWrap's proven commercial success and strong market momentum, Alafair is well-positioned to continue delivering innovative solutions that serve both the dedicated professionals who develop them and the patients who benefit from them.
Comments powered by CComment